Development of biomarker use in oncology clinical trials 2019

Key Findings and Implications

This document, published in cooperation by PMC (Personalized Medicine Coalition) and L.E.K. Consulting in November 2019, presents the latest information on the use of biomarkers in oncologic clinical trials. Biomarkers are the key for implementing personalized treatments to patients, and especially cancer patients.
  • Language: English
  • Released: November 2019
Study included in Corporate Account only.
More than 7,500
companies
trust
Statista
Recommended studies and dossiers
Show more
Recent studies and dossiers
You may also be interested in...
Statista is a great source of knowledge, and pretty helpful to manage the daily work.

Christof Baron about Statista CEO, MindShare Germany

Any more questions?

Get in touch with us quickly and easily.
We are happy to help!